Cumberland pharmaceuticals reports q2 loss per share of $0.06

Cumberland pharmaceuticals reports second quarter 2020 financial results & company update.q2 adjusted earnings per share $0.08.q2 loss per share $0.06.net revenues from continuing operations during quarter were $9.6 million.

CPIX Ratings Summary

CPIX Quant Ranking